CATALOGO DEI PRODOTTI DELLA RICERCA

MAGLIOZZI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.665
EU - Europa 3.930
AS - Asia 3.436
SA - Sud America 558
Continente sconosciuto - Info sul continente non disponibili 162
AF - Africa 132
OC - Oceania 12
Totale 12.895
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.526
RU - Federazione Russa 1.688
SG - Singapore 1.344
CN - Cina 925
GB - Regno Unito 552
IT - Italia 538
BR - Brasile 425
VN - Vietnam 344
HK - Hong Kong 321
SE - Svezia 217
FR - Francia 198
DE - Germania 196
IE - Irlanda 182
KR - Corea 103
FI - Finlandia 97
CA - Canada 81
BD - Bangladesh 80
TR - Turchia 59
ID - Indonesia 54
UA - Ucraina 50
IN - India 49
NL - Olanda 45
AR - Argentina 44
NG - Nigeria 44
AT - Austria 35
JP - Giappone 30
MX - Messico 30
EC - Ecuador 28
IQ - Iraq 25
PL - Polonia 25
CO - Colombia 19
ZA - Sudafrica 17
ES - Italia 16
BE - Belgio 15
UZ - Uzbekistan 15
AZ - Azerbaigian 11
BJ - Benin 11
EG - Egitto 11
MA - Marocco 11
TG - Togo 11
AE - Emirati Arabi Uniti 10
VE - Venezuela 10
CH - Svizzera 9
HR - Croazia 9
LT - Lituania 9
PK - Pakistan 9
AL - Albania 8
CL - Cile 8
PT - Portogallo 7
PY - Paraguay 7
TN - Tunisia 7
JM - Giamaica 6
NO - Norvegia 6
NZ - Nuova Zelanda 6
PH - Filippine 6
AU - Australia 5
BO - Bolivia 5
JO - Giordania 5
SA - Arabia Saudita 5
UY - Uruguay 5
BY - Bielorussia 4
DZ - Algeria 4
GR - Grecia 4
IL - Israele 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
PE - Perù 4
QA - Qatar 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
GY - Guiana 3
LV - Lettonia 3
MU - Mauritius 3
MY - Malesia 3
OM - Oman 3
BH - Bahrain 2
BS - Bahamas 2
CG - Congo 2
CR - Costa Rica 2
DK - Danimarca 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MK - Macedonia 2
NP - Nepal 2
PS - Palestinian Territory 2
RS - Serbia 2
SC - Seychelles 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CI - Costa d'Avorio 1
CY - Cipro 1
Totale 12.712
Salva come PNG Salva come JPEG
Città #
Ashburn 738
Singapore 663
Moscow 571
San Jose 511
Chandler 428
Southend 424
Dallas 377
Hong Kong 317
Council Bluffs 233
Verona 221
Jacksonville 189
Dublin 180
The Dalles 163
Beijing 160
Los Angeles 99
Ho Chi Minh City 97
Princeton 78
Lawrence 71
New York 67
Ann Arbor 65
Jinan 61
Columbus 59
Wilmington 58
Hanoi 57
Dong Ket 56
Santa Clara 54
Nanjing 53
Munich 51
Woodbridge 47
Istanbul 45
Tianjin 44
Houston 43
Redondo Beach 43
São Paulo 43
Buffalo 42
Redmond 42
Jakarta 40
Abuja 39
Lappeenranta 39
Rome 37
Helsinki 34
London 32
Milan 32
Shenyang 29
Changsha 28
Orem 26
Montreal 25
Nuremberg 25
Tokyo 25
Guangzhou 24
Ningbo 24
Zhengzhou 24
Montréal 23
Sindelfingen 23
Taizhou 22
Chennai 21
Haikou 21
Warsaw 21
Seattle 20
Vienna 20
Hebei 19
Redwood City 19
Atlanta 18
Frankfurt am Main 18
Hangzhou 18
Brooklyn 17
Lancaster 17
Nanchang 17
Seoul 17
Washington 17
Da Nang 16
Phoenix 16
Rio de Janeiro 16
Amsterdam 14
Chicago 14
Jiaxing 14
Brussels 13
Norwalk 13
Shanghai 13
Toronto 13
Mcallen 12
Tashkent 12
Baku 11
Bologna 11
Cotonou 11
Lomé 11
Manchester 11
Stockholm 11
Turku 11
Dhaka 10
Falls Church 10
Guayaquil 10
Johannesburg 10
Mexico City 10
Biên Hòa 9
Boston 9
Brasília 9
Denver 9
Haiphong 9
Baghdad 8
Totale 7.627
Salva come PNG Salva come JPEG
Nome #
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 312
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 241
Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events 233
Cerebrospinal fluid IgM levels in association with inflammatory pathways in multiple sclerosis patients 223
The CSF profile linked to cortical damage predicts Multiple Sclerosis activity 219
Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients 217
Iron loss of thalamic nuclei evaluated with quantitative susceptibility mapping is related to intrathecal macrophages activity and cortical pathology of multiple sclerosis 201
B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies 194
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis 188
The prognostic value of white-matter selective double inversion recovery mri sequence in multiple sclerosis: an exploratory study 185
Epilepsy in multiple sclerosis: The role of temporal lobe damage 184
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 173
CSF levels of CXCL12 and osteopontin as early markers of primary progressive multiple sclerosis 173
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 173
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 172
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis 171
Changes in cerebrospinal fluid balance of TNF and TNF receptors in naïve multiple sclerosis patients: early involvement in compartmentalised intrathecal inflammation 171
Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS 167
Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis 166
Heterogeneity of cortical lesion susceptibility mapping in multiple sclerosis 165
B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis 165
Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats 163
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis 163
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies 163
Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study 162
Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study 157
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage 154
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 151
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis 150
Mice repeatedly exposed to Group-A β-Haemolytic Streptococcus show perseverative behaviors, impaired sensorimotor gating, and immune activation in rostral diencephalon 150
Can CSF biomarkers predict future MS disease activity and severity? 150
B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis 150
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 148
Increased cortical lesion load and CSF cytokines in oligoclonal band positive MS patients 144
"Ependymal-in" gradient of thalamic damage in progressive multiple sclerosis 144
Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain 142
Repeated passive mobilization to stimulate vascular function in individuals of advanced age who are chronically bedridden. A randomized controlled trial 142
Aging, cellular senescence, and progressive Multiple Sclerosis 141
Exploring the origins of grey matter damage in multiple sclerosis. 140
A gradient of neuronal loss and meningeal inflammation in multiple sclerosis 137
Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells 133
Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis 131
Neuropathological and cerebrospinal fluid correlates of choroid plexus inflammation in progressive multiple sclerosis 130
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain 130
Intrathecal versus peripheral inflammatory protein profile in MS patients at diagnosis: a comprehensive investigation on serum and CSF 130
Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables 127
Chronic bedridden condition is reflected by substantial changes in plasma inflammatory profile 126
Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis 126
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis 125
The vascular side of chronic bed rest: when a therapeutic approach becomes deleterious 125
Acute TREM2 inhibition depletes MAFB-high microglia and hinders remyelination 123
The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis 123
Cortical surface-in gradient of alterations in magnetization transfer imaging in association with CSF soluble factors 121
A surface-in gradient of thalamic damage evolves in pediatric multiple sclerosis 121
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis 117
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology 117
Programmed death 1 is highly expressed on CD8+CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to EBV 114
Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination 114
Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation 114
Neonatal corticosterone mitigates autoimmune neuropsychiatric disorders associated with streptococcus in mice 114
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis 113
A disease-specific convergence of host and Epstein-Barr virus genetics in multiple sclerosis 112
Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein 112
Intracerebral regulation of immune responses 110
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis 109
Effects of the plasticiser DEHP on lung of newborn rats: catalase immunocytochemistry and morphometric analysis 106
MRI of cortical lesions and its use in studying their role in MS pathogenesis and disease course 106
The BAFF / APRIL system as therapeutic target in multiple sclerosis 105
Meningeal inflammation and cortical demyelination in acute multiple sclerosis 105
Detection of Epstein-Barr virus and B-cell follicles in the multiple sclerosis brain: what you find depends on how and where you look 103
Impact of neuronal loss on relaxometry and magnetization transfer imaging estimations 102
Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study 102
Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration 101
Lymphoid chemokines in chronic neuroinflammation 101
TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness 101
Characterization of cortico-meningeal translocator protein expression in multiple sclerosis 100
Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis 99
P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis 99
The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome 91
A glia-enriched stem cell 3D model of the human brain mimics the glial-immune neurodegenerative phenotypes of multiple sclerosis 89
Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue injury 89
Accelerated Cellular Senescence in Progressive Multiple Sclerosis: A Histopathological Study 88
snRNA-seq stratifies multiple sclerosis patients into distinct white matter glial responses 86
Surface-in pathology in multiple sclerosis: a new view on pathogenesis? 85
Overexpression of the ubiquitin-editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation 83
Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis 81
Intrathecal inflammation in progressive multiple sclerosis 81
Editorial: B cells in inflammatory and neurodegenerative diseases of the central nervous system 77
Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics 76
High levels of perivascular inflammation and active demyelinating lesions at time of death associated with rapidly progressive multiple sclerosis disease course: a retrospective post-mortem cohort study 74
Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosis 74
Differences in age-related retinal and cortical atrophy rates in multiple sclerosis 68
Relapsing meningitis and limbic encephalitis in anti-AQP4-Ab-associated neuromyelitis optica spectrum disorder 63
Comparing the pathology, clinical and demographic characteristics of younger and older-onset multiple sclerosis 61
Blood and CSF biomarkers for multiple sclerosis: emerging clinical applications 53
Editorial: Community series in reassessing the immune system contribution in multiple sclerosis: therapeutic target, biomarkers of disease and immune pathogenesis, volume II 50
Unsupervised Clustering Based on Quantitative Magnetic Resonance Imaging Features Contributes to the Characterization of MS White Matter Lesions 48
Choroid plexus volume predicts progression independent of relapse activity in early relapsing multiple sclerosis 42
Quantitative Magnetic resonance imaging lesion features allow machine learning-based classification of MS patients with Progression Independent of Relapse Activity 38
EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation 30
Totale 12.818
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.735
article - articoli 47.639
book - libri 0
conference - conferenze 2.096
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.470
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022349 0 0 1 72 18 7 19 40 20 19 30 123
2022/20231.208 86 147 115 223 68 282 22 69 157 4 18 17
2023/2024612 17 50 48 62 74 87 46 50 2 60 84 32
2024/20252.139 75 141 69 345 94 104 88 137 338 156 170 422
2025/20266.363 451 323 392 943 1.563 405 616 357 576 419 109 209
2026/2027456 124 185 147 0 0 0 0 0 0 0 0 0
Totale 12.895